Conference Coverage ACC 2017 See All Content See past conferences Washington, DC March 17, 2017 March 19, 2017 News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time My prediction? The biggest impact of ACC 2017 won’t come from a trial, a drug, or a device, but from the faces we saw in the Main Tent. < > FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017 News News Conference News ACC 2017 DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions Yael L. Maxwell March 19, 2017 News Conference News ACC 2017 iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions Caitlin E. Cox March 18, 2017 News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017 News Conference News ACC 2017 MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns L.A. McKeown March 27, 2017 News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017 Slides Presentation ACC 2017 First Results from the SURTAVI Clinical Trial Presenter: Michael J. Reardon March 17, 2017 Presentation ACC 2017 DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion Presenter: Seung-Jung Park March 20, 2017 Presentation ACC 2017 iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART Presenter: Matthias Götberg March 20, 2017 Presentation ACC 2017 The RAD-MATRIX Study Presenter: Alessandro Sciahbasi March 19, 2017 Presentation ACC 2017 Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017 Live Blog News Conference News ACC 2017 Live From Washington: ACC 2017, Day One Shelley Wood March 17, 2017 News Conference News ACC 2017 Live From Washington: ACC 2017, Day Two Shelley Wood March 18, 2017 News Conference News ACC 2017 Live From Washington: ACC 2017, Day Three Shelley Wood March 19, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time My prediction? The biggest impact of ACC 2017 won’t come from a trial, a drug, or a device, but from the faces we saw in the Main Tent.
FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 DECISION-CTO: PCI Stumbles for Stable CAD Patients With Chronic Total Occlusions Yael L. Maxwell March 19, 2017
News Conference News ACC 2017 iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions Caitlin E. Cox March 18, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Conference News ACC 2017 MitraClip Commercial Experience at 1 Year Sheds Light on Progress and Lingering Concerns L.A. McKeown March 27, 2017
News Conference News ACC 2017 TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes Shelley Wood March 24, 2017
Presentation ACC 2017 First Results from the SURTAVI Clinical Trial Presenter: Michael J. Reardon March 17, 2017
Presentation ACC 2017 DECISION-CTO: Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion Presenter: Seung-Jung Park March 20, 2017
Presentation ACC 2017 iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART Presenter: Matthias Götberg March 20, 2017
Presentation ACC 2017 Results of the CARAT Study: Effect of Serial Infusions of CER-001, a Pre-Beta High-Density Lipoprotein Mimetic on Coronary Atherosclerosis Presenter: Stephen J Nicholls March 20, 2017